We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$10.8B
AUM Growth
+$165M
Cap. Flow
-$365M
Cap. Flow %
-3.38%
Top 10 Hldgs %
12.81%
Holding
600
New
180
Increased
119
Reduced
126
Closed
156

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$187M
2
AAPL icon
Apple
AAPL
+$156M
3
SYK icon
Stryker
SYK
+$112M
4
JCI icon
Johnson Controls International
JCI
+$95.3M
5
DELL icon
Dell
DELL
+$92.7M

Top Sells

Rank Stock Value
1
EMC
EMC CORPORATION
EMC
+$126M
2
DVA icon
DaVita
DVA
+$115M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.5M
4
JNJ icon
Johnson & Johnson
JNJ
+$84.2M
5
MON
Monsanto Co
MON
+$81.5M

Sector Composition

Rank Sector Weight
1 Technology 16.04%
2 Healthcare 14.31%
3 Industrials 11.92%
4 Consumer Discretionary 11.79%
5 Consumer Staples 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTLA icon
426
Intellia Therapeutics
NTLA
$1.67B
$596K 0.01%
+35,000
New +$677K
ALPN
427
DELISTED
Alpine Immune Sciences Inc
ALPN
$571K 0.01%
17,551
+699
+4% +$17K
BIOA
428
CALL
DELISTED
BioAmber Inc.
BIOA
$571K 0.01%
134,568
+3,559
+3% +$13.2K
RXII
429
CALL
DELISTED
GALENA BIOPHARMA INC COM
RXII
$559K 0.01%
1,593,277
– –
ARGS
430
DELISTED
Argos Therapeutics, Inc.
ARGS
$554K 0.01%
+5,571
New +$582K
IBP icon
431
Installed Building Products
IBP
$6.49B
$503K ﹤0.01%
14,035
+1,766
+14% +$61.4K
GNRT
432
DELISTED
Gener8 Maritime, Inc.
GNRT
$489K ﹤0.01%
95,509
-383,027
-80% -$2.07M
WINT
433
CALL
DELISTED
Windtree Therapeutics Inc
WINT
$457K ﹤0.01%
178,570
– –
SCTL
434
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$456K ﹤0.01%
+57,555
New +$462K
NTBL
435
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$435K ﹤0.01%
2,381
– –
RLJE
436
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$430K ﹤0.01%
200,000
– –
SVRA icon
437
CALL
Savara
SVRA
$1.19B
$327K ﹤0.01%
42,420
– –
NVCN
438
DELISTED
Neovasc Inc.
NVCN
$268K ﹤0.01%
20
– –
ONCE
439
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$237K ﹤0.01%
+3,954
New +$228K
BLPH
440
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$214K ﹤0.01%
10,204
+406
+4% +$9.8K
TLND
441
DELISTED
Talend S.A. American Depositary Shares
TLND
$213K ﹤0.01%
+8,150
New +$217K
PARN
442
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$209K ﹤0.01%
147,458
– –
KALV
443
DELISTED
KalVista Pharmaceuticals
KALV
$74K ﹤0.01%
11,518
+459
+4% +$3.46K
GEVO icon
444
CALL
Gevo
GEVO
$382M
$47K ﹤0.01%
243
– –
ADI icon
445
Analog Devices
ADI
$190B
– –
-269,974
Closed -$15.3M
AEO icon
446
American Eagle Outfitters
AEO
$3.01B
– –
-1,125,823
Closed -$17.9M
AFL icon
447
Aflac
AFL
$62.6B
– –
-161,472
Closed -$5.83M
AGNC icon
448
AGNC Investment
AGNC
$12.9B
– –
-151,299
Closed -$3M
AGRO icon
449
Adecoagro
AGRO
$1.36B
– –
-357,839
Closed -$3.92M
AIV
450
Aimco
AIV
$383M
– –
-459,304
Closed -$2.7M
16 17
18
19 20

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q3 2016 Portfolio in Review

As of Q3 2016, Alyeska Investment Group held 600 positions worth $10.8B, up 1.5% from $10.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Alyeska Investment Group withdrew a net $365M in Q3 2016, closing 156 positions and reducing 126 holdings. Its most notable exit was EMC CORPORATION, an estimated $126M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in Alphabet (Google) Class C worth $192M.

  • Alyeska Investment Group's largest Q3 2016 buy was Alphabet (Google) Class C: 4,931,700 shares worth $192M.
  • Alyeska Investment Group added most to Apple in Q3 2016, an estimated $156M increase.
  • Alyeska Investment Group's biggest Q3 2016 reduction was Alphabet (Google) Class A, cutting an estimated $97.5M.
  • Alyeska Investment Group fully exited EMC CORPORATION in Q3 2016, selling an estimated $126M.
  • Alyeska Investment Group's ten largest holdings make up 13% of its $10.8B portfolio in Q3 2016.
  • Alyeska Investment Group opened 180 new positions and closed 156 in Q3 2016.
  • Alyeska Investment Group's portfolio value rose 1.5% quarter-over-quarter to $10.8B.

Based on Alyeska Investment Group's 13F filing for Q3 2016, filed 14 Nov 2016.